Sales of NRT smoking cessations are still enjoying current value growth in 2022. This is, firstly, thanks to a considerable increase in taxation implemented in January 2022. The Belgian Government raised the prices of tobacco products, with the price of a pack of 20 cigarettes being increased from EUR7.50 to EUR7.75, while the price of 50g of tobacco rose from EUR11 to EUR12. Further increases are also planned until 2024. Secondly, sales of NRT smoking cessations were also artificially boosted b...
Euromonitor International's NRT Smoking Cessation Aids in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
NRT Smoking Cessation Aids in Belgium
Euromonitor International
September 2022
List Of Contents And Tables
NRT SMOKING CESSATION AIDS IN BELGIUM
KEY DATA FINDINGS
2022 DEVELOPMENTS
New robust growth thanks to taxes on tobacco and prices increase
Tobacco consumption took off during the pandemic in contrast to initial assumptions
Nicorette maintains its position, giving Janssen-Cilag a strong lead in a limited category
PROSPECTS AND OPPORTUNITIES
Lower growth expected due to competition from e-vapour products and nicotine pouches
Faster-acting products and potential deregulation to maintain positive growth
New price hikes on legal tobacco but ongoing progression of illicit tobacco
CATEGORY INDICATORS
Table 1 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN BELGIUM
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources